Efficacy of Pharmacotherapy for Smoking Cessation in Adolescent Smokers: A Meta-analysis of Randomized Controlled Trials

Nicotine and Tobacco Research

Volumn 21, Issue 11, 2019, Pages 1473-1479

  Myung, Seung Kwon ^a   Park, Joo Young ^b  

^a National Cancer Center   (South Korea)

^b Seoul Science High School   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; COCHRANE LIBRARY; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; EMBASE; FEMALE; FOLLOW UP; HUMAN; MALE; MEDLINE; META ANALYSIS; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SCHOOL CHILD; SMOKING CESSATION; SYSTEMATIC REVIEW; ADOLESCENT BEHAVIOR; CHILD HEALTH CARE; TOBACCO DEPENDENCE; YOUNG ADULT;

ADOLESCENT; ADOLESCENT BEHAVIOR; ADOLESCENT HEALTH SERVICES; CHILD; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SMOKING CESSATION; TOBACCO USE CESSATION DEVICES; TOBACCO USE DISORDER; YOUNG ADULT;

EID: 85074263851     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/nty180     Document Type: Article

References (25)

1. World Health Organization. Media Centre: Tobacco. Updated May 2017. http://www.who.int/mediacentre/factsheets/fs339/en/. Accessed February 4, 2018.
2. Centers for Disease Control and Prevention. Smoking & Tobacco Use: Basic Information. https://www.cdc.gov/tobacco/basic_information/index. htm. Accessed February 4, 2018.
3. Benowitz NL. Nicotine addiction. N Engl J Med. 2010;362(24):2295-2303.
4. Fiore MC, Jaén C, Baker T, et al. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service; 2008.
5. Stead LF, Lancaster T. Behavioural interventions as adjuncts to pharmacotherapy for smoking cessation. Cochrane Database Syst Rev. 2012;12:CD009670.
6. Cahill K, Stevens S, Perera R, Lancaster C. Pharmacological interventions for smoking cessation: An overview and network meta-analysis. Cochrane Database Syst Rev. 2013;(5):CD009329.
7. Marshall L, Schooley M, Ryan H, et al.; Centers for Disease Control and Prevention. Youth tobacco surveillance-United States, 2001-2002. MMWR Surveill Summ. 2006;55(3):1-56.
8. Pirie K, Peto R, Reeves GK, Green J, Beral V; Million Women Study Collaborators. The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK. Lancet. 2013;381(9861):133-141.
9. Moss AJ, Allen KF, Giovino GA, Mills SL. Recent trends in adolescent smoking, smoking-uptake correlates, and expectations about the future. Adv Data. 1992;117(221):1-28.
10. Kim Y, Myung SK, Jeon YJ, et al. Effectiveness of pharmacologic therapy for smoking cessation in adolescent smokers: meta-analysis of randomized controlled trials. Am J Health Syst Pharm. 2011;68(3):219-226.
11. Bailey SR, Crew EE, Riske EC, Ammerman S, Robinson TN, Killen JD. Efficacy and tolerability of pharmacotherapies to aid smoking cessation in adolescents. Paediatr Drugs. 2012;14(2):91-108.
12. Fanshawe TR, Halliwell W, Lindson N, Aveyard P, Livingstone-Banks J, Hartmann-Boyce J. Tobacco cessation interventions for young people. Cochrane Database Syst Rev. 2017;11:CD003289.
13. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1-12.
14. Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration; 2011. Available from http://handbook.cochrane.org. Accessed February 4, 2018.
15. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539-1558.
16. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629-634.
17. Hanson K, Allen S, Jensen S, Hatsukami D. Treatment of adolescent smokers with the nicotine patch. Nicotine Tob Res. 2003;5(4):515-526.
18. Killen JD, Robinson TN, Ammerman S, et al. Randomized clinical trial of the efficacy of bupropion combined with nicotine patch in the treatment of adolescent smokers. J Consult Clin Psychol. 2004;72(4):729-735.
19. Niederhofer H, Huber M. Bupropion may support psychosocial treatment of nicotine-dependent adolescents: preliminary results. Pharmacotherapy. 2004;24(11):1524-1528.
20. Moolchan ET, Robinson ML, Ernst M, et al. Safety and efficacy of the nicotine patch and gum for the treatment of adolescent tobacco addiction. Pediatrics. 2005;115(4):e407-e414.
21. Roddy E, Romilly N, Challenger A, Lewis S, Britton J. Use of nicotine replacement therapy in socioeconomically deprived young smokers: a community-based pilot randomised controlled trial. Tob Control. 2006;15(5):373-376.
22. Muramoto ML, Leischow SJ, Sherrill D, Matthews E, Strayer LJ. Randomized, double-blind, placebo-controlled trial of 2 dosages of sustained-release bupropion for adolescent smoking cessation. Arch Pediatr Adolesc Med. 2007;161(11):1068-1074.
23. Rubinstein ML, Benowitz NL, Auerback GM, Moscicki AB. A randomized trial of nicotine nasal spray in adolescent smokers. Pediatrics. 2008;122(3):e595-e600.
24. Gray KM, Carpenter MJ, Baker NL, et al. Bupropion SR and contingency management for adolescent smoking cessation. J Subst Abuse Treat. 2011;40(1):77-86.
25. Scherphof CS, van den Eijnden RJ, Engels RC, Vollebergh WA. Long-term efficacy of nicotine replacement therapy for smoking cessation in adolescents: A randomized controlled trial. Drug Alcohol Depend. 2014;140:217-220.